Track topics on Twitter Track topics that are important to you
Acerus Pharmaceuticals (TSX:ASP) announced today that Hyundai Pharm Co., Ltd. (Hyundai), Acerus’ licensee, reported that South Korea’s Ministry of Food and Drug Safety (MFDS) has approved NATESTO® for the treatment of hypogonadism. As quoted in the press release: “Acerus is very pleased by the speed with which Hyundai has been able to prepare the dossier and … Continued
The post Acerus Announces Approval of NATESTO in South Korea appeared first on Investing News Network.
Original Article: Acerus Announces Approval of NATESTO in South KoreaNEXT ARTICLE
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...